• Return to Headlines

Incyte Corp Up 20.4% Since SmarTrend Uptrend Call (INCY)

By Amy Schwartz

SmarTrend identified an Uptrend for Incyte Corp (NASDAQ:INCY) on October 15th, 2019 at $78.21. In approximately 2 months, Incyte Corp has returned 20.37% as of today's recent price of $94.14.

Incyte Corp share prices have moved between a 52-week high of $153.15 and a 52-week low of $83.01 and are now trading 13% above that low price at $94.14 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.1% while the 200-day MA has risen 0.2%.

Incyte Corporation is a biopharmaceutical company. The Company discovers, develops, and commercializes proprietary small molecule drugs, primarily used in oncology.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Incyte Corp shares.

Log in and add Incyte Corp (INCY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights incyte corp

Ticker(s): INCY